Cargando…
Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia
OBJECTIVES: Cancer cachexia affects the majority of tumor patients and significantly contributes to high mortality rates in these subjects. Despite its clinical importance, the identity of tumor-borne signals and their impact on specific peripheral organ systems, particularly the heart, remain mostl...
Autores principales: | Schäfer, Michaela, Oeing, Christian U., Rohm, Maria, Baysal-Temel, Ezgi, Lehmann, Lorenz H., Bauer, Ralf, Volz, H. Christian, Boutros, Michael, Sohn, Daniela, Sticht, Carsten, Gretz, Norbert, Eichelbaum, Katrin, Werner, Tessa, Hirt, Marc N., Eschenhagen, Thomas, Müller-Decker, Karin, Strobel, Oliver, Hackert, Thilo, Krijgsveld, Jeroen, Katus, Hugo A., Berriel Diaz, Mauricio, Backs, Johannes, Herzig, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735665/ https://www.ncbi.nlm.nih.gov/pubmed/26909315 http://dx.doi.org/10.1016/j.molmet.2015.11.004 |
Ejemplares similares
-
‘Corrigendum to “Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia” [Molecular Metabolism 5 (2) (2015) 67–78]’
por: Schäfer, Michaela, et al.
Publicado: (2020) -
Obesity and cancer—extracellular matrix, angiogenesis, and adrenergic signaling as unusual suspects linking the two diseases
por: Pellegata, Natalia S., et al.
Publicado: (2022) -
FOX-2 Dependent Splicing of Ataxin-2 Transcript Is Affected by Ataxin-1 Overexpression
por: Welzel, Franziska, et al.
Publicado: (2012) -
Experimental ischaemic stroke induces transient cardiac atrophy and dysfunction
por: Veltkamp, Roland, et al.
Publicado: (2018) -
TSC22D4 is a molecular output of hepatic wasting metabolism
por: Jones, Allan, et al.
Publicado: (2013)